Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(836 sites)

United States

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Thomas Hospital, Fairhope, Alabama

Mobile Infirmary Medical Center, Mobile, Alabama

University of South Alabama Mitchell Cancer Institute, Mobile, Alabama

Katmai Oncology Group, Anchorage, Alaska